Investor Relations

Sunshine Heart is a global medical technology company, committed to the commercialization of C-Pulse®, an implantable, non-blood contacting, heart assist therapy for the treatment of people with class III and ambulatory class IV heart failure. Sunshine Heart is listed on the NASDAQ Capital Market.

Press Releases

Posted on Jul 30, 2015
EDEN PRAIRIE, Minn., July 30, 2015 (GLOBE NEWSWIRE) -- Sunshine Heart (NASDAQ:SSH) announced today an update on its next generation, fully implantable version of the Company's flagship C-Pulse® technology. Sunshine Heart is pleased to report that it will commence a first-in-human study using th...

Read More

Posted on Jul 28, 2015
EDEN PRAIRIE, Minn., July 28, 2015 (GLOBE NEWSWIRE) -- Sunshine Heart, Inc. (NASDAQ:SSH) today announced that its second quarter 2015 results will be released on Tuesday, August 4, 2015, before the open of the stock market. The company will host a conference call and webcast at 9:00 AM ET that morni...

Read More

Posted on Jul 23, 2015
EDEN PRAIRIE, Minn., July 23, 2015 (GLOBE NEWSWIRE) -- Sunshine Heart, Inc. (NASDAQ:SSH) announced today an update on its COUNTER HF™ US pivotal study for the C-Pulse Heart Assist System. COUNTER HF is a prospective, randomized, multi-center, controlled study evaluating the safety and efficacy...

Read More

Events & Presentations

Posted on Aug 4, 2015 at 9:00 AM ET
Posted on Aug 29, 2015